Faster, Better? Fujitsu, Polarisqb 'Quantum-Inspired' Tech Speeds Discovery
Promise Vs Coronavirus?
Executive Summary
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.
You may also be interested in...
Latecomer Alunbrig Faces Entrenched Rivals After US 1L Approval
First-line lung cancer approval will expand potential market for Takeda's ALK contender but the latecomer is also facing some well-established class competition in the setting.
Post-IPO Zentalis Plows New Ground With China Oncology Venture
US venture raises new funds from Asia partners as it builds a direct presence in China to develop its oncology portfolio.
Japan To Reimburse Zolgensma – But At Lower Price Than US
Novartis gene therapy gets insurance coverage at record price although small patient population will limit system costs.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports